Combining AD‐PRSnoAPOE, APOE‐RS, and p‐tau181 improved the discrimination of MCI+/AD from controls (81%) and LBD (75%), and the detection of Aβ in LBD (82%). This evidence concerns the gene APOE and Alzheimer disease.